News

Deal Announcements

Cold Genesys Lands Series A Venture Capital

Monday, August 4, 2014 5:30:00 AM PDT | VentureDeal
   Newport Beach, California  --  Biotechnology company Cold Genesys has secured $13.57 million in its first round of venture capital funding.

Cold Genesys is continuing clinical trials of its lead product, CG0070, a potential treatment for patients with non-muscle invasive bladder cancer.

Ally Bridge Group made the investment.

The company did not provide details on exactly how the proceeds would be used.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1